69 results
6-K
EX-99.1
MESO
Mesoblast Ltd
11 Mar 24
Current report (foreign)
6:50pm
disease and death worldwide. European Society of Cardiology. 2014; 1: 4-25 7. Gustafsson F, Rogers JG. Left ventricular assist device therapy
6-K
EX-99.2
MESO
Mesoblast Ltd
29 Feb 24
Current report (foreign)
6:15pm
2022) ASTCT = American Society for Transplantation and Cellular Therapy; CIBMTR = Center for International Blood and Marrow Transplant Research 16 m e s
6-K
EX-99.3
MESO
Mesoblast Ltd
28 Nov 23
Current report (foreign)
9:32pm
with Remestemcel-L for Steroid-Refractory Acute Graft Versus-Host Disease on a Phase 3, Single- Arm, Prospective Study (Nov 2022) ASTCT = American Society
6-K
EX-99.2
MESO
Mesoblast Ltd
22 Nov 23
Current report (foreign)
7:20pm
Society for Transplantation and Cellular Therapy; CIBMTR = Center for International Blood and Marrow Transplant Research 16 m e s o b l a s t Remestemcel
6-K
EX-99.1
amg 3c6be
26 May 23
Current report (foreign)
7:56am
6-K
EX-99.2
86oifa1xfw44d lxgy
26 May 23
Current report (foreign)
7:56am
6-K
rs5ma63mj55bmh5y
25 May 23
Current report (foreign)
9:33pm
6-K
EX-99.1
qya8zgvh9 m4z
3 May 23
Appendix 4C Quarterly Activity Report
8:21am
S-8 POS
EX-99.1
mb0 30d5oc
20 Dec 22
Registration of securities for employees (post-effective amendment)
6:40am
S-8 POS
EX-99.1
g61n4
20 Dec 22
Registration of securities for employees (post-effective amendment)
6:38am
S-8 POS
EX-99.1
jrkw006fkvllobgvcm
20 Dec 22
Registration of securities for employees (post-effective amendment)
6:37am
S-8 POS
EX-99.1
tso6ivbd p7n7
20 Dec 22
Registration of securities for employees (post-effective amendment)
6:36am
S-8 POS
EX-99.1
4d7yi7xrrpmu
20 Dec 22
Registration of securities for employees (post-effective amendment)
6:35am
6-K
EX-99.1
3r0uzlxjbjyt
5 Aug 22
Appendix 4C Quarterly Activity Report
6:26am
6-K
EX-99.2
x9d 46tam
20 Jul 22
Current report (foreign)
8:20pm
6-K
EX-99.1
fonnad1rlm96kyyjt
14 Jul 22
Rexlemestrocel-l to Be Highlighted at Maxim’s Panel on Late-stage Advancements In Heart Failure Therapeutics and Management
4:00pm
6-K
k39m899vcm51abjqn
2 Jun 22
Current report (foreign)
7:50pm
6-K
qb6ug4qg6mig9q3
25 Feb 22
Provided to the Asx Under Listing Rule 4.2A
12:00am